How is KPV administered?
This describes how KPV is typically administered in clinical and research references, not a self-administration guide. The usual route is Oral, sub-q, or topical, on a daily schedule, generally over 4-8 weeks. Specific dosing is individual and beyond general information, and human evidence for KPV is limited.
Administration at a glance (reference data)
- Route: Oral, sub-q, or topical
- Schedule: Daily
- Cycle length: 4-8 weeks
- Half-life: ~hours (poorly characterized)
References
- Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease — Kannengiesser K, Maaser C, Heidemann J, Luegering A, Ross M, Brzoska T, Böhm M, Luger TA, Domschke W, Kucharzik T — Inflammatory Bowel Diseases, 2008;14(3):324-31
- Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis — Xiao B, Xu Z, Viennois E, et al. — Molecular Therapy, 2017;25(7):1628-1640
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on KPV
Last updated 2026-06-15.